• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer

    2018-03-08 06:26:34WuhaoHuangShengguangWangHuaZhangBinZhangChangliWang
    Cancer Biology & Medicine 2018年1期

    Wuhao Huang, Shengguang Wang, Hua Zhang, Bin Zhang, Changli Wang

    Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Ministry of Education, Tianjin’s Clinical Research Center for Cancer; Tianjin Lung Cancer Center, Tianjin 300060, China

    Introduction

    Lung cancer is the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC)accounting for approximately 80% of all cases1. Despite the recent improvements in treatment and diagnosis of lung cancer, its prognosis remains unsatisfactory, with a low fiveyear survival rate of about 15% at diagnosis. Currently, the new strategy in tumor therapy focuses on using a suitable prognostic factor to make the appropriate risk classification of patients with tumors and to design subsequent treatment.Although multiple studies have found a large number of prognostic indicators for patients with NSCLC, the majority of these indicators are not available preoperatively.

    Cancer-related inflammation plays an important role in tumor progression and survival2. Cancer-related inflammation, as the 7thhallmark of cancer, promotes the proliferation and invasion of tumor cells and accelerates metastasis3. Moreover, most systemic symptoms associated with cancer, including weight loss, cachexia, and anemia, are stimulated by inflammation4. The neutrophil-to-lymphocyte ratio (NLR), as a representative index, can be considered a useful marker to assess the inflammatory response5. An increased NLR promotes tumor progression and relates to poor prognoses in a variety of cancers, such as NSCLC,esophageal cancer, and gastric cancer6-8. In terms of the systemic inflammatory response, the coagulation cascade also plays a pivotal role in tumor progression and metastasis9.Liver-produced fibrinogen is an important acute phase protein. Fibrinogen, as a key factor in the coagulation cascade, is converted into fibrin under the action of activated thrombin. Hyperfibrinogenemia is involved in cancer aggressiveness in various types of malignancies10-12. Recently,several studies analyzed a novel prognostic index, that is, the combination of fibrinogen and NLR (F-NLR). F-NLR has been found to be a significant prognostic factor in different types of cancers, such as gastric cancer, esophageal carcinoma, and NSCLC13-16.

    The present study aimed to evaluate the clinical significance of a novel prognostic system based on fibrinogen concentration and NLR in patients with NSCLC undergoing complete resection. This study also assessed the association between the three F-NLR groups and the clinicopathologic characteristics or the clinical laboratory variables.

    Materials and methods

    Patients

    We performed a retrospective study of patients with NSCLC who underwent complete surgical resection at the Tianjin Medical University Cancer Institute and Hospital between January 2006 and December 2009. The major inclusion criteria were pathological confirmation of primary NSCLC and complete surgical resection. The exclusion criteria were as follows: preoperative treatment (including chemotherapy or radiotherapy), residual tumor cells in the surgical edge,continuous anticoagulant therapy, hematological disease,autoimmune disease, and infection. Patients with intravenous or arterial embolization within 3 months before the surgery were also excluded. Based on the inclusion and exclusion criteria, 589 patients were enrolled in our study.This study was approved by the Ethical Committees of Tianjin Medical University Cancer Institute and Hospital.Prior to the treatment, and written informed consent from all participants were acquired.

    Based on the medical records, we collected the patients’clinicopathologic parameters and laboratory inspections,such as age, sex, histopathology, TNM stage, and blood cell count. Tumor stages were determined according to the 7thedition of the TNM classification17.

    F-NLR definition

    Hematological indexes, including lymphocyte count,neutrophil count, and fibrinogen concentration, were obtained from the routine blood test administered a week prior to the surgery. The neutrophil count divided by the lymphocyte count was defined as the NLR. Receiver operating characteristic (ROC) curve analysis was used to determine the cut-off values for the preoperative fibrinogen concentration and NLR. According to the ROC curve analysis, the most appropriate cut-off point for NLR was 2.30, with an area under the curve of 0.635. Therefore, we recommended 2.30 as the cut-off value for NLR. Similarly,the optimal point based on the ROC curve showed a cut-off value of 3.48 g/L for fibrinogen, with an area under the curve of 0.595. Consequently, we defined 3.48 g/L as the optimal cut-off value for fibrinogen.

    Based on these cut-off values, we calculated the F-NLR score. Patients with both a high NLR (≥ 2.30) and hyperfibrinogenemia (≥ 3.48 g/L) were given a score of 2.Patients with either high NLR (≥ 2.30) or hyperfibrinogenemia (≥ 3.48 g/L) were given a score of 1. Patients without either abnormality were scored 0.

    Statistical analysis

    Chi-square and Kruskal-Wallis tests were applied to evaluate the differences between the three F-NLR groups and the clinicopathologic characteristics or clinical laboratory variables. Continuous variables are presented as mean ± SD.We carried out the ROC curve analysis to select the appropriate cut-off values for NLR, fibrinogen, and the clinical laboratory variables. These clinical laboratory variables included fibrinogen, lactate dehydrogenase (LDH),D-dimer, neutrophil ratio, monocyte ratio, lymphocyte ratio,white blood cell (WBC) count, platelet count, hemoglobin(Hb), and alkaline phosphatase (ALP). The outcomes of this study were disease-free survival (DFS) and overall survival(OS). DFS was defined as the time in months from the date of surgery to the date of first progression or last follow-up.OS was defined as the time in months from the date of surgery to the date of death or last follow-up. Survival analysis was performed using the Kaplan-Meier survival curve. Univariate and multivariate analyses, which were carried out by Cox regression models, were used to determine the prognostic factors. SPSS version 18.0 (SPSS Inc., Chicago, IL) was utilized for statistical analyses. A P value of < 0.05 was considered statistically significant.

    Results

    Patient characteristics

    A total of 589 patients who were pathologically diagnosed with NSCLC were included in this study. All patients underwent surgery for early-stage NSCLC. Tables 1 and 2 illustrate the relationship of the clinicopathologic variables and clinical laboratory parameters with patients grouped by their F-NLR score. The present study included 390 (66.2%)men and 199 (33.8%) women, ranging 24–82 years (medianage: 60 years). The allocation of the F-NLR score was as follows: F-NLR = 0, 207 (35.1%) patients; F-NLR = 1, 154(26.2%) patients; and F-NLR = 2, 228 (38.7%) patients. A total of 278, 120, and 191 patients presented with pathological stages I, II, and IIIA, respectively. The median and mean follow-up periods were 44 and 44.3 months,respectively. The five-year OS rate in the entire study population was 50.3%.

    Table 1 Correlation between preoperative F-NLR and clinicopathologic characteristics of patients with NSCLC

    Table 2 Correlation between preoperative F-NLR and clinical laboratory characteristics of patients with NSCLC

    Correlation between the clinicopathologic variables or clinical laboratory parameters and F-NLR

    The association between the F-NLR and clinicopathologic indexes of patients with NSCLC is shown in Table 1. We found significant correlation of F-NLR with age (P = 0.005),gender (P = 0.006), smoking (P = 0.014), lesion (P < 0.001),resection type (P < 0.001), pathological stage (P < 0.001),histology (P < 0.001), lymph node metastasis (P = 0.028),and tumor size (P < 0.001).

    The clinical laboratory variable distribution in the three FNLR groups is presented in Table 2. Significant differences among these three groups were demonstrated in the following indexes: age (P = 0.001), maximum tumor diameter (P < 0.001), NLR (P < 0.001), fibrinogen (P <0.001), neutrophil ratio (P < 0.001), lymphocyte ratio (P <0.001), WBC count (P < 0.001), platelet count (P < 0.001),ALP (P < 0.001), and survival period (P < 0.001).

    Survival analysis of F-NLR

    We performed the Kaplan-Meier analysis and log-rank test to determine the survival differences among the three groups classified by F-NLR score. The five-year DFS rate and the median survival in patients with F-NLR = 2 were significantly lower than those in patients with F-NLR = 1 or F-NLR = 0[30.4% vs. 50.3% or 62.2% (22.5 vs. 36.0 or 42.0 months),P < 0.001; Figure 1A]. The five-year OS rates were 66.1%,53.5%, and 33.3%, and the median survival times were 51.0,46.0, and 33.0 months for F-NLR = 0, F-NLR = 1, and F-NLR= 2, respectively (P < 0.001, Figure 1B). When the pathological stages (I, II, and IIIA) were analyzed separately,the DFS and OS of patients with F-NLR = 0 were higher than those with F-NLR = 1 or F-NLR = 2 in stages I and IIIA(stage I: P < 0.001 for DFS, P < 0.001 for OS, Figures 2A and 2B; stage IIIA: P = 0.001 for DFS, P < 0.001 for OS, Figures 2E and 2F). However, no significant relationship was observed between F-NLR and prognosis in patients with stage II NSCLC (P = 0.149 for DFS and P = 0.139 for OS,Figures 2C and 2D). Further analyses were conducted in subgroups (adenocarcinoma and squamous carcinoma). We demonstrated that patients with F-NLR = 0 displayed a higher DFS and OS than those with F-NLR = 1 or F-NLR = 2 in the adenocarcinoma and squamous carcinoma subgroups(adenocarcinoma: P < 0.001 for DFS, P < 0.001 for OS,Figures 3A and 3B; squamous carcinoma: P < 0.001 for DFS,P < 0.001 for OS, Figures 3C and 3D).

    Figure 1 Survival curves of patients with non-small cell lung cancer (NSCLC) (stages I-IIIA) in the combination of fibrinogen and neutrophil-to-lymphocyte ratio (F-NLR). (A) Disease-free survival (DFS) curve of patients with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (B) Overall survival (OS) curve of patients with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test,P > 0.001).

    Univariate and multivariate analyses of variables are shown in Tables 3 and 4, respectively. Based on the cut-off values, we separated the patients into different groups.Univariate analysis demonstrated that lesion (P = 0.023 for DFS and P = 0.014 for OS), resection type (P = 0.041 for DFS and P = 0.038 for OS), pathological stage (P < 0.001 for DFS and P < 0.001 for OS), tumor size (P < 0.001 for DFS and P <0.001 for OS), adjuvant radiotherapy (P = 0.001 for DFS and P = 0.004 for OS), F-NLR score (P < 0.001 for DFS and P <0.001 for OS), NLR (P < 0.001 for DFS and P < 0.001 for OS), fibrinogen (P < 0.001 for DFS and P < 0.001 for OS),LDH (P = 0.003 for DFS and P = 0.005 for OS), D-dimer(P < 0.001 for DFS and P = 0.002 for OS), neutrophil ratio(P < 0.001 for DFS and P < 0.001 for OS), monocyte ratio(P = 0.008 for DFS and P = 0.006 for OS), lymphocyte ratio(P < 0.001 for DFS and P < 0.001 for OS), WBC count (P =0.007 for DFS and P = 0.008 for OS), ALP (P = 0.002 for DFS and P = 0.003 for OS), and Hb (P = 0.022 for DFS and P =0.040 for OS) were correlated with DFS and OS.

    Multivariate analysis of independent prognostic indicators

    Figure 2 Survival curves of patients with NSCLC (stage I-IIIA) in F-NLR. (A) DFS curve of patients with stage I NSCLC with F-NLR=0, FNLR=1, and F-NLR=2 (log-rank test, P > 0.001). (B) OS curve of patients with stage I NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (C) DFS curve of patients with stage II NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P = 0.149). (D) OS curve of patients with stage II NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P = 0.139). (E) DFS curve of patients with stage IIIA NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P = 0.001). (F) OS curve of patients with stage IIIA NSCLC with F-NLR=0, FNLR=1, and F-NLR=2 (log-rank test, P > 0.001).

    Figure 3 Survival curves of patients with adenocarcinoma or squamous carcinoma in F-NLR. (A) DFS curve of patients with adenocarcinoma with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (B) OS curve of patients with adenocarcinoma with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001).(C) DFS curve of patients with squamous carcinoma with F-NLR=0,F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (D) OS curve of patients with squamous carcinoma with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001).

    To determine the independent predictive indexes, further Cox multivariate analysis, which included the variables mentioned above, was performed. As shown in Table 4,multivariate analysis revealed that F-NLR was significantly related to DFS and OS [hazard ratio (HR), 1.466; 95%confidence interval (CI), 1.243–1.730; P < 0.001 for DFS and HR, 1.512; 95% CI, 1.283–1.783; P < 0.001 for OS,respectively] along with pathological stage and D-dimer.Therefore, multivariate analysis demonstrated that F-NLR was considered an independent prognostic indicator for DFS and OS.

    Discussion

    Although substantial developments have been made in the treatment and diagnosis of lung cancer, the median survival of NSCLC remains unsatisfactory. An appropriate prognostic factor may enable the suitable risk classification of patients with tumors and allow the assignment of appropriate prospective treatment. Cancer progression and survival are not determined solely by the tumor characteristics. Patientrelated factors also play a crucial role in survival. Based on the preoperative blood specimens collected from 589 patients, we investigated the prognostic significance of FNLR. We also analyzed the association between F-NLR and clinicopathologic or clinical laboratory characteristics.

    In the last few decades, inflammation has been increasingly accepted as a hallmark of cancer3. Inflammation can increase the risk of cancer by producing bioactive molecules from the cells infiltrating the tumor microenvironment. Inflammationrelated cells introduce crucial cytokines to the tumor microenvironment, thereby promoting the growth,angiogenesis, invasion, metastasis, and survival of cancer cells18-20. Increasing evidence has revealed that systemic inflammation responses are crucial prognostic indicators21.NLR is a systemic inflammation index, which is calculated by dividing the neutrophil count by the lymphocyte count.Lymphocytes, as key components of the host’s anticancer immunity, perform important functions in immunosurveillance and immunoediting and contribute to the inhibition of tumor cell proliferation and migration21. T lymphocytes exert a killing effect on target cells and help induce tumor cell apoptosis in cancer patients22. Increased amounts of circulating blood lymphocytes are an advantageous prognostic index in resected NSCLC23,24. Similar to lymphocytes, neutrophils are recognized as important components of tumor inflammation and immunology.Circulating neutrophils can produce a variety of cytokines,including tumor necrosis factor-α, vascular endothelial growth factor (VEGF), and interleukin, which can promote tumor progression25,26. Neutrophil extracellular traps, which are secreted by neutrophils, can contribute to tumor metastasis by sequestering the tumor cell27. Donskov28reported that increased neutrophil levels infiltrating the tumor tissue and circulating in the blood are insufficient prognostic indexes in several cancers, including colorectal cancer, lung cancer, and head and neck cancer. With the combination of neutrophil and lymphocyte counts, NLR can be used as a representative index to indicate a systemic inflammatory response in patients with various cancers6-8.

    Hyperfibrinogenemia is involved in tumor aggressiveness in various malignancies10-12. Although many studies have investigated the causes of hyperfibrinogenemia in malignant tumors, the underlying mechanism remains unclear. Liverproduced fibrinogen is a major acute-phase protein. When a malignant neoplasm or systemic inflammation is present, the fibrinogen level in the plasma is increased; this fibrinogen can be transformed into fibrin by activated thrombin. Yamaguchi et al.29indicated that cancer cells can produce interleukin-6,which accelerates the secretion of fibrinogen in patients with lung cancer. Similarly, Sahni et al.30found that tumor cellscan synthesize fibrinogen. Fibrinogen eventually stimulates tumor proliferation and angiogenesis by its interaction with VEGF and fibroblast growth factor-230,31. When fibrinogen is converted, fibrin is involved in metastasis and new vessel formation32,33. Palumbo et al.34demonstrated that the fibrin formed around circulating tumor cells can prevent natural killer cells from killing tumor cells.

    Table 3 Univariate analysis for DFS and OS

    Hence, F-NLR presents a good prognostic indicator for patients with cancer. Fibrinogen or NLR alone may exert a limited effect on tumor progression. F-NLR increases the unfavorable effect of fibrinogen and NLR, which eventually increases the predicted significance for patients with cancer.Recently, Wang et al.16reported that patients with a low FNLR score may exhibit a better prognosis than those with a high F-NLR score and that the preoperative F-NLR score can be considered a useful independent prognostic marker,consistent with the results of our study. In the present study,multivariate analysis using the characteristics selected in univariate analysis revealed that preoperative F-NLR was significantly correlated with DFS and OS, as well as pathological stage and D-dimer. According to the results of the Kaplan-Meier analysis and log-rank test, our study revealed that the preoperative F-NLR level can stratify the patients into different risk categories. Moreover, when the patients with different pathological stages were analyzed separately, the DFS and OS in the patients with F-NLR = 0 were higher than those with F-NLR = 1 or F-NLR = 2 in stage I and IIIA. However, in patients with stage II NSCLC, thecorrelation between F-NLR and prognosis was insignificant,which indicates that F-NLR may be more predictive in stage I or IIIA cancers than in stage II. Our study also found that the preoperative F-NLR level was significantly correlated with both DFS and OS in patients with adenocarcinoma or squamous carcinoma. Furthermore, a close relationship was observed between F-NLR and pathological stage, lesion,lymph node metastasis, and tumor size. To reveal the pathological status of tumor progression, preoperative FNLR levels calculated from blood specimens should be evaluated. The advantage of the F-NLR score was based on the fibrinogen concentration and NLR, which were obtained from the routine blood sample analysis. Therefore, F-NLR may serve as a more inexpensive and widespread hematologic marker than other tumor markers.

    Table 4 Multivariate analysis for DFS and OS

    This study had some limitations. First, this study was a retrospective analysis and all data were obtained from a single institute. Second, although we restricted the influence of other factors, blood cell counts can be influenced by a variety of factors.

    Conclusions

    The preoperative F-NLR score can be considered a valuable prognostic indicator in patients with NSCLC after surgery. A close relationship between F-NLR and cancer progression was also observed in patients with NSCLC who underwent surgery. Thus, F-NLR may be considered for routine clinical use as a reliable and low-cost biomarker.

    This work was supported by grants from National Key R&D Program of China (Grant No. 2016YFC0905501) and the Tianjin Science and Technology Major Project, China (Grant No. 12ZCDZSY15400).

    Conflict of interest statement

    No potential conflicts of interest are disclosed.

    1.Siegel R, Ma JM, Zou ZH, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29.

    2.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74.

    3.Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancerrelated inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009; 30: 1073-81.

    4.Scott HR, McMillan DC, Forrest LM, Brown DJF, McArdle CS,Milroy R. The systemic inflammatory response, weight loss,performance status and survival in patients with inoperable nonsmall cell lung cancer. Br J Cancer. 2002; 87: 264-7.

    5.Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophillymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol. 2013; 88: 218-30.

    6.Takahashi Y, Horio H, Hato T, Harada M, Matsutani N, Morita S,et al. Prognostic significance of preoperative neutrophil-lymphocyte ratios in patients with stage I non-small cell lung cancer after complete resection. Ann Surg Oncol. 2015; 22:1324-31.

    7.Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI,et al. Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.Ann Surg Oncol. 2011; 18: 3362-9.

    8.Cho IR, Park JC, Park CH, Jo JH, Lee HJ, Kim S, et al. Pretreatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014; 17:703-10.

    9.Zacharski LR, Meehan KR, Algarra SM, Calvo FA. Clinical trials with anticoagulant and antiplatelet therapies. Cancer Metastasis Rev. 1992; 11: 421-31.

    10.Son HJ, Park JW, Chang HJ, Kim DY, Kim BC, Kim SY, et al.Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol. 2013; 20: 2908-13.

    11.Lu K, Zhu Y, Sheng LM, Liu LY, Shen L, Wei QC. Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer. Hepatogastroenterology. 2011;58: 1507-10.

    12.Sheng LM, Luo M, Sun XJ, Lin NM, Mao WM, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer. 2013; 133: 2720-5.

    13.Arigami T, Uenosono Y, Matsushita D, Yanagita S, Uchikado Y,Kita Y, et al. Combined fibrinogen concentration and neutrophillymphocyte ratio as a prognostic marker of gastric cancer. Oncol Lett. 2016; 11: 1537-44.

    14.Arigami T, Uenosono Y, Ishigami S, Okubo K, Kijima T, Yanagita S, et al. A novel scoring system based on fibrinogen and the neutrophil-lymphocyte ratio as a predictor of chemotherapy response and prognosis in patients with advanced gastric cancer.Oncology. 2016; 90: 186-92.

    15.Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y,Kita Y, et al. Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine (Baltimore).2015; 94: e1702

    16.Wang HY, Zhao J, Zhang MY, Han LJ, Wang M, Li XD. The combination of plasma fibrinogen and neutrophil lymphocyte ratio(F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. J Cell Physiol. 2017; doi: 10.1002/jcp.26239. (in Press)

    17.Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming(seventh) edition of the TNM Classification of malignant tumours.J Thorac Oncol. 2007; 2: 706-14.

    18.DeNardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010; 29: 309-16.

    19.Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883-99.

    20.Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141: 39-51.

    21.Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454: 436-44.

    22.Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W,Lotze M, et al. Decreased ζ chain expression and apoptosis in CD3+peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res. 2001; 7: 947S-57S.

    23.Zhang J, Huang SH, Li H, Li Y, Chen XL, Zhang WQ, et al.Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol.2013; 30: 352

    24.Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, Onizuka M, et al.Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer. 2012;75: 223-7.

    25.Ulich TR, del Castillo J, Keys M, Granger GA, Ni RX. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol. 1987; 139: 3406-15.

    26.Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH.Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003; 6: 283-7.

    27.Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S,Giannias B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013;123: 3446-58.

    28.Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013; 23: 200-7.

    29.Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M, Ogura T. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol. 1998; 28:740-4.

    30.Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW.Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost.2008; 6: 176-83.

    31.Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.Blood. 2000; 96: 3772-8.

    32.Wojtukiewicz MZ, Sierko E, Klemont P, Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001; 3: 371-84.

    33.Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix. Mol Biothechnol. 2002; 21: 85-90.

    34.Palumbo JS, Talmage KE, Massari JV, La jeunesse CM, Flick MJ,Kombrinck KW, et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005; 105: 178-85.

    中文字幕色久视频| 韩国精品一区二区三区| 日本精品一区二区三区蜜桃| 日本a在线网址| 一进一出抽搐动态| 精品高清国产在线一区| 久久久久久人人人人人| 丰满的人妻完整版| 1024视频免费在线观看| 国产av一区在线观看免费| 欧美国产精品va在线观看不卡| 波多野结衣高清无吗| 国产精品久久久久久精品电影 | 免费人成视频x8x8入口观看| 熟女少妇亚洲综合色aaa.| 在线国产一区二区在线| 久久久久久人人人人人| 久久久国产精品麻豆| 欧美色视频一区免费| 天堂影院成人在线观看| 一区二区三区激情视频| 欧美激情 高清一区二区三区| 亚洲黑人精品在线| 国产精品亚洲av一区麻豆| 99精品在免费线老司机午夜| 亚洲 国产 在线| 久久精品影院6| 1024视频免费在线观看| 国产片内射在线| 老熟妇乱子伦视频在线观看| 欧美在线黄色| 夜夜爽天天搞| 午夜久久久久精精品| 亚洲国产精品合色在线| 男女做爰动态图高潮gif福利片 | 亚洲一区二区三区不卡视频| 亚洲第一av免费看| cao死你这个sao货| 黄色丝袜av网址大全| 97人妻天天添夜夜摸| 精品国产一区二区三区四区第35| 黄片小视频在线播放| 色综合亚洲欧美另类图片| 久久久久久久久中文| 亚洲国产欧美网| 看片在线看免费视频| 国产精品免费视频内射| 亚洲精品中文字幕在线视频| 午夜影院日韩av| 深夜精品福利| 变态另类丝袜制服| 亚洲精品国产精品久久久不卡| 免费高清在线观看日韩| 国产精品av久久久久免费| 欧美成人性av电影在线观看| 91国产中文字幕| 久久这里只有精品19| 久久久久国产一级毛片高清牌| 国产成人啪精品午夜网站| 夜夜躁狠狠躁天天躁| 男男h啪啪无遮挡| 欧美国产精品va在线观看不卡| 欧美日韩黄片免| 欧美黄色片欧美黄色片| 可以在线观看的亚洲视频| 看免费av毛片| 人人妻人人澡欧美一区二区 | 看免费av毛片| 最好的美女福利视频网| 男女下面插进去视频免费观看| 精品午夜福利视频在线观看一区| 国产精品98久久久久久宅男小说| 亚洲,欧美精品.| 丝袜人妻中文字幕| 脱女人内裤的视频| 国产亚洲精品第一综合不卡| 欧美在线一区亚洲| 久久国产精品人妻蜜桃| 日本免费一区二区三区高清不卡 | 两性午夜刺激爽爽歪歪视频在线观看 | 欧美日韩黄片免| 国产成年人精品一区二区| 两性夫妻黄色片| 国产成人av激情在线播放| 精品一区二区三区视频在线观看免费| 午夜福利,免费看| tocl精华| 日日摸夜夜添夜夜添小说| 自线自在国产av| 成人亚洲精品一区在线观看| 色av中文字幕| 一区二区三区激情视频| АⅤ资源中文在线天堂| 亚洲成a人片在线一区二区| 美国免费a级毛片| 亚洲国产毛片av蜜桃av| 亚洲七黄色美女视频| 91麻豆av在线| 一二三四在线观看免费中文在| 他把我摸到了高潮在线观看| 香蕉国产在线看| 啦啦啦韩国在线观看视频| 999久久久国产精品视频| 国产成人精品在线电影| 校园春色视频在线观看| 精品国产亚洲在线| 十八禁网站免费在线| 亚洲一卡2卡3卡4卡5卡精品中文| 亚洲一区二区三区不卡视频| 久久国产精品男人的天堂亚洲| av视频在线观看入口| 国产激情久久老熟女| 国产精品一区二区精品视频观看| 99在线人妻在线中文字幕| 美女 人体艺术 gogo| netflix在线观看网站| 色在线成人网| 中亚洲国语对白在线视频| 欧美大码av| 每晚都被弄得嗷嗷叫到高潮| 免费看美女性在线毛片视频| 精品午夜福利视频在线观看一区| 久热爱精品视频在线9| 欧美激情 高清一区二区三区| 一区在线观看完整版| 麻豆一二三区av精品| 国产av在哪里看| 亚洲精品中文字幕一二三四区| 国产激情久久老熟女| 亚洲成人免费电影在线观看| or卡值多少钱| 国产片内射在线| 色哟哟哟哟哟哟| 淫秽高清视频在线观看| 欧洲精品卡2卡3卡4卡5卡区| 欧美亚洲日本最大视频资源| 亚洲狠狠婷婷综合久久图片| 在线播放国产精品三级| 亚洲 国产 在线| 日本免费a在线| 亚洲av电影不卡..在线观看| 99久久久亚洲精品蜜臀av| 国产精品自产拍在线观看55亚洲| 丰满人妻熟妇乱又伦精品不卡| 成人特级黄色片久久久久久久| АⅤ资源中文在线天堂| 色av中文字幕| 国产精品综合久久久久久久免费 | 中文字幕久久专区| 无遮挡黄片免费观看| 一个人观看的视频www高清免费观看 | 精品少妇一区二区三区视频日本电影| 亚洲精品美女久久av网站| 午夜老司机福利片| 亚洲五月色婷婷综合| 啦啦啦 在线观看视频| 97超级碰碰碰精品色视频在线观看| 亚洲最大成人中文| 精品乱码久久久久久99久播| 在线av久久热| 亚洲电影在线观看av| 国产成人精品在线电影| 亚洲欧洲精品一区二区精品久久久| 色哟哟哟哟哟哟| av在线天堂中文字幕| 美女扒开内裤让男人捅视频| 亚洲专区中文字幕在线| 中文字幕另类日韩欧美亚洲嫩草| 欧美久久黑人一区二区| 天天躁狠狠躁夜夜躁狠狠躁| 制服诱惑二区| 一边摸一边抽搐一进一出视频| 亚洲成人国产一区在线观看| aaaaa片日本免费| 欧美不卡视频在线免费观看 | 两个人免费观看高清视频| 一区在线观看完整版| 一本综合久久免费| 老汉色av国产亚洲站长工具| 色综合欧美亚洲国产小说| 亚洲国产高清在线一区二区三 | 人成视频在线观看免费观看| 免费一级毛片在线播放高清视频 | 91老司机精品| 精品国产一区二区三区四区第35| 欧美人与性动交α欧美精品济南到| 午夜福利影视在线免费观看| 亚洲av成人av| 免费久久久久久久精品成人欧美视频| 成人国产一区最新在线观看| 这个男人来自地球电影免费观看| 女人爽到高潮嗷嗷叫在线视频| 久久精品国产亚洲av香蕉五月| 国产欧美日韩一区二区精品| 精品福利观看| 黑丝袜美女国产一区| 欧美中文综合在线视频| 久久久久久人人人人人| 欧美成人一区二区免费高清观看 | 人成视频在线观看免费观看| 精品国产国语对白av| 黄色女人牲交| 无人区码免费观看不卡| 成年版毛片免费区| 国产精品爽爽va在线观看网站 | 亚洲精品av麻豆狂野| 99re在线观看精品视频| 18禁黄网站禁片午夜丰满| 亚洲午夜精品一区,二区,三区| 久久精品影院6| 91麻豆av在线| 久久婷婷成人综合色麻豆| 久久人妻熟女aⅴ| 亚洲天堂国产精品一区在线| 免费少妇av软件| 两性夫妻黄色片| 国产免费男女视频| 国产一区二区三区综合在线观看| 丝袜美足系列| 美女高潮喷水抽搐中文字幕| 国产成人啪精品午夜网站| 男人舔女人的私密视频| 两性夫妻黄色片| 日韩国内少妇激情av| 欧美黄色片欧美黄色片| 欧洲精品卡2卡3卡4卡5卡区| 在线观看免费视频日本深夜| 巨乳人妻的诱惑在线观看| 国产精品亚洲美女久久久| 啦啦啦免费观看视频1| 母亲3免费完整高清在线观看| 50天的宝宝边吃奶边哭怎么回事| 国产av在哪里看| 欧美在线一区亚洲| 久久午夜综合久久蜜桃| 不卡一级毛片| 国产高清激情床上av| 这个男人来自地球电影免费观看| 国产精品一区二区免费欧美| 欧美日韩黄片免| 99热只有精品国产| 99香蕉大伊视频| 亚洲精品av麻豆狂野| 99久久久亚洲精品蜜臀av| 天堂√8在线中文| 国产精华一区二区三区| 夜夜夜夜夜久久久久| 一级毛片女人18水好多| 日本黄色视频三级网站网址| av欧美777| 色播亚洲综合网| www.熟女人妻精品国产| 国语自产精品视频在线第100页| 国产又爽黄色视频| 99国产精品一区二区蜜桃av| 午夜福利成人在线免费观看| 国产精品综合久久久久久久免费 | 久久午夜综合久久蜜桃| 国产xxxxx性猛交| 中文字幕人妻熟女乱码| 久热爱精品视频在线9| 亚洲九九香蕉| 啦啦啦韩国在线观看视频| 欧美黑人精品巨大| 日本vs欧美在线观看视频| 亚洲成人免费电影在线观看| 一级片免费观看大全| 一区二区三区国产精品乱码| 午夜福利,免费看| 久久久久国产一级毛片高清牌| 女人被躁到高潮嗷嗷叫费观| 91国产中文字幕| 老熟妇乱子伦视频在线观看| 视频区欧美日本亚洲| 精品午夜福利视频在线观看一区| 亚洲五月色婷婷综合| 久久人妻av系列| 亚洲专区字幕在线| 在线永久观看黄色视频| 黄色片一级片一级黄色片| 国语自产精品视频在线第100页| 人人妻人人爽人人添夜夜欢视频| 好男人在线观看高清免费视频 | 国产精品电影一区二区三区| 亚洲国产高清在线一区二区三 | 91字幕亚洲| 亚洲无线在线观看| 亚洲成国产人片在线观看| 亚洲最大成人中文| 国产一卡二卡三卡精品| 69精品国产乱码久久久| 国产精品一区二区免费欧美| 国产亚洲精品av在线| 女性被躁到高潮视频| 欧美激情 高清一区二区三区| 国产麻豆69| 757午夜福利合集在线观看| 亚洲第一av免费看| 叶爱在线成人免费视频播放| 午夜精品久久久久久毛片777| 欧美一级毛片孕妇| 精品高清国产在线一区| 欧美+亚洲+日韩+国产| 99国产精品免费福利视频| 丝袜人妻中文字幕| 首页视频小说图片口味搜索| 国产熟女xx| 天天躁狠狠躁夜夜躁狠狠躁| 极品教师在线免费播放| 亚洲成a人片在线一区二区| 9191精品国产免费久久| 亚洲全国av大片| 黄色视频不卡| bbb黄色大片| 丁香六月欧美| 午夜福利,免费看| 久久久国产成人精品二区| 久久精品91蜜桃| 精品免费久久久久久久清纯| 黑人操中国人逼视频| 久久精品影院6| 国产日韩一区二区三区精品不卡| 1024香蕉在线观看| 国产人伦9x9x在线观看| 亚洲激情在线av| 欧美另类亚洲清纯唯美| 午夜福利欧美成人| 亚洲国产中文字幕在线视频| 国产成人系列免费观看| 国内精品久久久久久久电影| 亚洲中文字幕一区二区三区有码在线看 | 在线免费观看的www视频| 成熟少妇高潮喷水视频| 午夜福利18| 精品国产一区二区久久| 亚洲精品中文字幕在线视频| 国产熟女午夜一区二区三区| 一进一出抽搐gif免费好疼| 一边摸一边抽搐一进一小说| 欧美日韩精品网址| 精品免费久久久久久久清纯| 女性被躁到高潮视频| 欧美日韩中文字幕国产精品一区二区三区 | 性少妇av在线| 丝袜美足系列| 精品无人区乱码1区二区| 黄片播放在线免费| 最新美女视频免费是黄的| 成人国产综合亚洲| 日韩欧美一区二区三区在线观看| 久久九九热精品免费| 最近最新中文字幕大全电影3 | 久久精品国产99精品国产亚洲性色 | 亚洲午夜理论影院| 此物有八面人人有两片| 精品久久久久久久毛片微露脸| av片东京热男人的天堂| 91精品国产国语对白视频| 久久精品国产清高在天天线| 欧美成人一区二区免费高清观看 | 18美女黄网站色大片免费观看| 亚洲天堂国产精品一区在线| 一级a爱视频在线免费观看| 欧美激情极品国产一区二区三区| 国产97色在线日韩免费| 国产精品一区二区精品视频观看| 宅男免费午夜| 久久这里只有精品19| 亚洲欧美日韩另类电影网站| 99国产精品免费福利视频| 成年女人毛片免费观看观看9| 精品人妻1区二区| 久久狼人影院| 久久九九热精品免费| 亚洲欧洲精品一区二区精品久久久| 久久欧美精品欧美久久欧美| 国产精品av久久久久免费| 精品第一国产精品| 欧美+亚洲+日韩+国产| 淫秽高清视频在线观看| 午夜成年电影在线免费观看| 动漫黄色视频在线观看| 91av网站免费观看| 色av中文字幕| 亚洲欧美激情在线| 国产成年人精品一区二区| 亚洲免费av在线视频| 亚洲欧美精品综合一区二区三区| 国产精品九九99| 亚洲成国产人片在线观看| 丝袜美足系列| 欧美黑人精品巨大| 国产熟女午夜一区二区三区| 黄色成人免费大全| 亚洲熟妇中文字幕五十中出| bbb黄色大片| 欧美精品啪啪一区二区三区| 99在线人妻在线中文字幕| aaaaa片日本免费| 国产一级毛片七仙女欲春2 | 99国产极品粉嫩在线观看| 18禁裸乳无遮挡免费网站照片 | 黄色视频,在线免费观看| 国产精品久久视频播放| 国产免费男女视频| 国产精品,欧美在线| 桃色一区二区三区在线观看| 久久国产精品影院| 欧美日韩乱码在线| 久久人人爽av亚洲精品天堂| 欧美日本亚洲视频在线播放| 国产精品久久久久久人妻精品电影| netflix在线观看网站| 亚洲,欧美精品.| 成熟少妇高潮喷水视频| 黄色 视频免费看| av超薄肉色丝袜交足视频| 成人18禁高潮啪啪吃奶动态图| 波多野结衣高清无吗| av超薄肉色丝袜交足视频| 色婷婷久久久亚洲欧美| 99精品欧美一区二区三区四区| 女警被强在线播放| 亚洲精品中文字幕在线视频| 欧美黑人精品巨大| 如日韩欧美国产精品一区二区三区| 色综合婷婷激情| 亚洲,欧美精品.| av片东京热男人的天堂| 国产视频一区二区在线看| 欧美日本中文国产一区发布| 黄色片一级片一级黄色片| 亚洲欧美激情在线| 51午夜福利影视在线观看| 波多野结衣巨乳人妻| 两个人免费观看高清视频| aaaaa片日本免费| 国产精品1区2区在线观看.| 精品久久久久久久久久免费视频| 欧美性长视频在线观看| 亚洲男人天堂网一区| 久久性视频一级片| 精品久久久精品久久久| 91精品三级在线观看| 日韩一卡2卡3卡4卡2021年| 久久国产精品影院| 国产一区二区三区综合在线观看| 亚洲avbb在线观看| 久久欧美精品欧美久久欧美| 两性夫妻黄色片| 中文字幕精品免费在线观看视频| 国产精品,欧美在线| 性欧美人与动物交配| 午夜两性在线视频| 母亲3免费完整高清在线观看| 精品久久久久久久人妻蜜臀av | cao死你这个sao货| 午夜日韩欧美国产| av欧美777| 午夜久久久在线观看| 少妇粗大呻吟视频| 十八禁人妻一区二区| 午夜福利影视在线免费观看| 99国产精品免费福利视频| 欧美日韩亚洲国产一区二区在线观看| 天天躁夜夜躁狠狠躁躁| 亚洲国产欧美一区二区综合| 女人爽到高潮嗷嗷叫在线视频| 欧美成人午夜精品| 日韩成人在线观看一区二区三区| 99国产综合亚洲精品| 黄色毛片三级朝国网站| 波多野结衣av一区二区av| 国产亚洲av嫩草精品影院| 女人爽到高潮嗷嗷叫在线视频| 色综合站精品国产| 亚洲第一电影网av| 久久狼人影院| 免费不卡黄色视频| 乱人伦中国视频| 久久九九热精品免费| 亚洲三区欧美一区| 精品久久久久久久毛片微露脸| 国内精品久久久久精免费| 亚洲美女黄片视频| 18禁裸乳无遮挡免费网站照片 | 国产高清有码在线观看视频 | 午夜视频精品福利| 日本a在线网址| netflix在线观看网站| 深夜精品福利| 级片在线观看| 在线观看免费视频网站a站| 少妇的丰满在线观看| 老熟妇仑乱视频hdxx| 男人的好看免费观看在线视频 | 国产亚洲精品久久久久5区| 制服人妻中文乱码| 国产欧美日韩一区二区三| 色综合欧美亚洲国产小说| 久久精品aⅴ一区二区三区四区| 亚洲第一电影网av| 午夜福利18| 亚洲免费av在线视频| 日韩免费av在线播放| 日韩有码中文字幕| 一进一出抽搐gif免费好疼| 麻豆国产av国片精品| 两性午夜刺激爽爽歪歪视频在线观看 | 午夜福利视频1000在线观看 | 午夜福利,免费看| 精品久久久久久成人av| 国产一区在线观看成人免费| 久久九九热精品免费| 一边摸一边做爽爽视频免费| 美女高潮喷水抽搐中文字幕| 日本在线视频免费播放| 日韩欧美国产一区二区入口| 99香蕉大伊视频| 亚洲精品一卡2卡三卡4卡5卡| 一夜夜www| 免费在线观看日本一区| 亚洲av美国av| 欧洲精品卡2卡3卡4卡5卡区| av在线播放免费不卡| 亚洲免费av在线视频| 午夜影院日韩av| 精品无人区乱码1区二区| 韩国精品一区二区三区| 久久香蕉激情| 91字幕亚洲| 国内毛片毛片毛片毛片毛片| 亚洲精品av麻豆狂野| 久久中文看片网| 日韩欧美国产在线观看| 国产又爽黄色视频| 国产亚洲欧美98| 妹子高潮喷水视频| 18禁裸乳无遮挡免费网站照片 | 亚洲精品久久国产高清桃花| 777久久人妻少妇嫩草av网站| 久久久精品欧美日韩精品| 韩国av一区二区三区四区| 欧美日韩中文字幕国产精品一区二区三区 | 国产单亲对白刺激| 午夜福利高清视频| 黄色片一级片一级黄色片| 777久久人妻少妇嫩草av网站| 国产欧美日韩精品亚洲av| 一级毛片精品| 亚洲,欧美精品.| 丰满人妻熟妇乱又伦精品不卡| 日韩欧美三级三区| 久久国产精品人妻蜜桃| 国产精品二区激情视频| 亚洲国产精品久久男人天堂| 久久精品aⅴ一区二区三区四区| 亚洲成a人片在线一区二区| 最好的美女福利视频网| 亚洲免费av在线视频| 纯流量卡能插随身wifi吗| 18禁裸乳无遮挡免费网站照片 | 久久九九热精品免费| 一区二区三区高清视频在线| 狠狠狠狠99中文字幕| 欧美不卡视频在线免费观看 | 日本vs欧美在线观看视频| 午夜影院日韩av| e午夜精品久久久久久久| 人人妻,人人澡人人爽秒播| 一进一出抽搐动态| 国产av在哪里看| 久久久久久亚洲精品国产蜜桃av| 久久久国产欧美日韩av| 最新在线观看一区二区三区| 国产真人三级小视频在线观看| 精品午夜福利视频在线观看一区| 午夜福利欧美成人| 国产单亲对白刺激| 国产真人三级小视频在线观看| 后天国语完整版免费观看| 一进一出抽搐gif免费好疼| 波多野结衣一区麻豆| 老司机靠b影院| 很黄的视频免费| 久久人人97超碰香蕉20202| aaaaa片日本免费| 国产男靠女视频免费网站| 亚洲精品国产一区二区精华液| 日韩欧美一区二区三区在线观看| √禁漫天堂资源中文www| 自线自在国产av| 亚洲成av人片免费观看| 999久久久精品免费观看国产| 美女 人体艺术 gogo| 天天躁狠狠躁夜夜躁狠狠躁| 法律面前人人平等表现在哪些方面| 国产在线观看jvid| 色尼玛亚洲综合影院| 中文字幕人妻丝袜一区二区| 国产精品一区二区免费欧美| 免费高清视频大片| 一级毛片精品| 欧美成人性av电影在线观看| 亚洲欧美精品综合一区二区三区| 男人操女人黄网站| 一边摸一边做爽爽视频免费| 国产av又大| 亚洲精品一区av在线观看| 久久草成人影院| 精品国产美女av久久久久小说| 精品久久久久久久久久免费视频| 国产av精品麻豆| 国产免费男女视频| 又大又爽又粗|